Toniana G. Carvalho

Toniana G. Carvalho

Auto-generated profile, based on publicly available information

Toniana G. Carvalho

Department of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
IOIsabella G. Olmo
Isabella G. Olmo
TCToniana G. Carvalho
Toniana G. Carvalho
VCVivian V. Costa
Vivian V. Costa
JAJuliana Alves-Silva
Juliana Alves-Silva
CFCarolina Zaniboni Ferrari
Carolina Zaniboni Ferrari
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro
Zika virus (ZIKV) has recently caused a worldwide outbreak of infections associated with severe neurological complications, including microcephaly in infants born from infected mothers. ZIKV exhibits high neurotropism and promotes neuroinflammation and neuronal cell death. We have recently demonstrated that N-methyl-D-aspartate receptor (NMDAR) blockade by memantine prevents ZIKV-induced neuronal cell death. Here we show that ZIKV induces apoptosis in a non-cell autonomous manner, triggering cell death of uninfected neurons by releasing cytotoxic factors. Neuronal cultures infected with ZIKV exhibit increased levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and glutamate. Moreover, infected neurons exhibit increased expression of GluN2B and augmented intracellular Ca2+ concentration. Blockade of GluN2B-containing NMDAR by ifenprodil normalizes Ca2+ levels and rescues neuronal cell death. Notably, TNF-α and IL-1β blockade decreases ZIKV-induced Ca2+ flux through GluN2B-containing NMDARs and reduces neuronal cell death, indicating that these cytokines might contribute to NMDAR sensitization and neurotoxicity. In addition, ZIKV infected cultures treated with ifenprodil exhibits increased activation of the neuroprotective pathway including extracellular signal-regulated kinase (ERK) and cAMP response element binding protein (CREB), which may underlie ifenprodil-mediated neuroprotection. Together, our data shed some light on the neurotoxic mechanisms triggered by ZIKV and begin to elucidate how GluN2B-containing NMDAR blockade can prevent neurotoxicity.

12 March 2013 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
JDJg Doria
Jg Doria
FSFr Silva
Fr Silva
JSJm de Souza
Jm de Souza
LVLb Vieira
Lb Vieira
TCTg Carvalho
Tg Carvalho
FRFm Ribeiro
Fm Ribeiro
Background and Purpose: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion in the huntingtin protein. We have previously demonstrated that the cell signalling of the metabotropic glutamate receptor 5 (mGluR5) is altered in a mouse model of HD. Although mGluR5‐dependent protective pathways are more activated in HD neurons, intracellular Ca2+ release is also more pronounced, which could contribute to excitotoxicity. In the present study, we aim to investigate whether mGluR5 positive allosteric modulators (PAMs) could activate protective pathways without triggering high levels of Ca2+ release and be neuroprotective in HD.Experimental Approach: We performed a neuronal cell death assay to determine which drugs are neuroprotective, Western blot and Ca2+ release experiments to investigate the molecular mechanisms involved in this neuroprotection, and object recognition task to determine whether the tested drugs could ameliorate HD memory deficit.Key Results: We find that mGluR5 PAMs can protect striatal neurons from the excitotoxic neuronal cell death promoted by elevated concentrations of glutamate and NMDA. mGluR5 PAMs are capable of activating Akt without triggering increased intracellular Ca2+ concentration ([Ca2+]i); and Akt blockage leads to loss of PAM‐mediated neuroprotection. Importantly, PAMs' potential as drugs that may be used to treat neurodegenerative diseases is highlighted by the neuroprotection exerted by mGluR5 PAMs on striatal neurons from a mouse model of HD, BACHD. Moreover, mGluR5 PAMs can activate neuroprotective pathways more robustly in BACHD mice and ameliorate HD memory deficit.Conclusions and Implications: mGluR5 PAMs are potential drugs that may be used to treat neurodegenerative diseases, especially HD.

1 January 2015 in Neurobiology of Disease
Verified
Journal Article
Closed access
JDJ.G. Doria
J.G. Doria
JSJ.M. de Souza
J.M. de Souza
JAJ.N. Andrade
J.N. Andrade
HRH.A. Rodrigues
H.A. Rodrigues
IGI.M. Guimaraes
I.M. Guimaraes
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro

10 April 2015 in Molecular Brain
Verified
Journal Article
Open access
PDF file
IGIsabella M Guimaraes
Isabella M Guimaraes
TCToniana G Carvalho
Toniana G Carvalho
SFStephen Sg Ferguson
Stephen Sg Ferguson
GPGrace S Pereira
Grace S Pereira
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro
The metabotropic glutamate receptor 5 (mGluR5) is involved in various brain functions, including memory, cognition and motor behavior. Regarding locomotor activity, we and others have demonstrated that pharmacological antagonism of mGluR5 promotes hyperkinesia in mice. Moreover, increased locomotor activity can also be observed in mice following the genetic deletion of mGluR5. However, it is still unclear which specific brain substrates contribute to mGluR5-mediated regulation of motor function. Thus, to better understand the role of mGluR5 in motor control and to determine which neural substrates are involved in this regulation we performed stereotactic microinfusions of the mGluR5 antagonist, MPEP, into specific brain regions and submitted mice to the open field and rotarod apparatus. Our findings indicate that mGluR5 blockage elicits distinct outcomes in terms of locomotor activity and motor coordination depending on the brain region injected with mGluR5 antagonist. MPEP injection into either the dorsal striatum or dorsal hippocampus resulted in increased locomotor activity, whereas MPEP injection into either the ventral striatum or motor cortex resulted in hypokinesia. Moreover, MPEP injected into the olfactory bulb increased the distance mice traveled in the center of the open field arena. With respect to motor coordination on the rotarod, injection of MPEP into the motor cortex and olfactory bulb elicited decreased latency to fall. Taken together, our data suggest that not only primarily motor neural substrates, but also limbic and sensory structures are involved in mGluR5-mediated motor behavior.

20 July 2018 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
JDJuliana G. Doria
Juliana G. Doria
JSJessica M. de Souza
Jessica M. de Souza
FSFlavia R. Silva
Flavia R. Silva
IOIsabella G. Olmo
Isabella G. Olmo
TCToniana G. Carvalho
Toniana G. Carvalho
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro

1 June 2019 in Neurochemistry International
Verified
Journal Article
Closed access
TCToniana G. Carvalho
Toniana G. Carvalho
JAJuliana Alves-Silva
Juliana Alves-Silva
JSJessica M. de Souza
Jessica M. de Souza
ARAna L.C.V. Real
Ana L.C.V. Real
JDJuliana G. Doria
Juliana G. Doria
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro